Sema3d restrained the progression of hepatocellular carcinoma proliferation, invasion, and metastasis through inactivating Pi3k/Akt, which may serve as a novel prognostic predictor and a potential therapeutic target for HCC patients. The gene discussed is SEMA3D; the disease is hepatocellular carcinoma.